A new topical agent, MC-1101 (MacuCLEAR), aims to treat dry AMD by increasing choroidal blood flow. Age-related macular degeneration (AMD) is the leading cause of severe visual impairment in developed countries.1 It now affects 1.75 million people in the US, and this number will likely grow as the population ages. Dry, or atrophic, AMD is [...]

More...